Congressional Research Service Issues In Focus White Paper on FDA's Oversight of Hemp-Derived Compounds
August 19, 2023
August 19, 2023
WASHINGTON, Aug. 19 -- The Congressional Research Service issued the following In Focus white paper (No. IF12477) on the FDA's oversight of hemp-derived compounds on Aug. 18, 2023, by agricultural policy specialist Renee Johnson.
Here are excerpts:
* * *
FDA's Oversight of Hemp-Derived Compounds
In January 2023, the Food and Drug Administration (FDA) issued a statement that the agency would "work with Congress" to develop &q . . .
Here are excerpts:
* * *
FDA's Oversight of Hemp-Derived Compounds
In January 2023, the Food and Drug Administration (FDA) issued a statement that the agency would "work with Congress" to develop &q . . .